Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
Key: Seneca Biopharma, Inc. (0) Acquired (2)
nsi-189 (3 trials)
tranexamic acid (cyklokapron) (4 trials)
Key: Seneca Biopharma, Inc. (0) Acquired (4)
cellulose (1 trial)
human spinal cord stem cells (1 trial)
nsi-566 (1 trial)
zd03 (1 trial)
Depression (Phase 2)
Depressive Disorder (Phase 2)
Depressive Disorder, Major (Phase 2)
Disease (Phase 2)
Ischemia (Phase 1)
Spinal Cord Injuries (Phase 1)
Stroke (Phase 1)
Trials (10 total)
Trial APIs (6 total)